当前位置：药药网 / 数据中心 /奥大利亚药品评审报告(本栏目收费,不能显示细节,电话15274084725)
药品名称：
活性成份：
发布日期：-
奥大利亚药品评审报告745个记录(本栏目收费,不能显示细节,电话15274084725)
奥大利亚药品评审报告
41
Dovato
Dolutegravir/Lamivudine
2019/12/4
42
ArTiMist 6
Artemether
2019/12/4
43
Polivy
Polatuzumab vedotin
2019/12/3
44
Mayzent
Siponimod
2019/12/11
45
Praluent
Alirocumab (rch)
2019/12/9
46
Cresemba
Isavuconazole (as sulphate)
2019/12/17
47
Vaxigrip Tetra
Inactivated quadrivalent influenza vaccine (split virion)
2019/12/19
48
Ajovy
Fremanezumab
2019/12/18
49
Clobex
Clobetasol propionate
2013/5/22
50
Opdivo
Nivolumab
2016/8/23
51
Celebrex
Celecoxib
2010/6/23
52
Exforge HCT / Ejocia HCT
Amlodipine (as besylate) / Valsartan / Hydrochlorothiazide
2010/8/26
53
Menveo
Meningococcal conjugated vaccine
2010/5/20
54
Invega
Paliperidone
2009/12/14
55
Lucrin Depot / Lucrin XL Depot
Leuprorelin acetate
2010/7/30
56
Rasilamlo
Aliskiren / Amlodipine
2011/8/5
57
Osteovan / Aclasta
Zoledronic acid
2011/8/31
58
Albumex 20 / Albumex 5 / Albumex 4
Albumin (human)
2011/7/27
59
Menactra
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Groups A, C, Y and W-135
2011/8/31
60
TachoSil
Human Fibrinogen / Human Thrombin
2012/8/31